Connor, Clark & Lunn Investment Management (CC&L)’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-174,356
| Closed | -$1.42M | – | 1408 |
|
|
2024
Q1 | $1.42M | Buy |
174,356
+6,138
| +4% | +$50.1K | 0.01% | 781 |
|
|
2023
Q4 | $950K | Buy |
168,218
+3,496
| +2% | +$19.8K | ﹤0.01% | 876 |
|
|
2023
Q3 | $306K | Sell |
164,722
-9,637
| -6% | -$17.9K | ﹤0.01% | 1139 |
|
|
2023
Q2 | $479K | Buy |
174,359
+60,466
| +53% | +$166K | ﹤0.01% | 992 |
|
|
2023
Q1 | $358K | Buy |
113,893
+99,436
| +688% | +$312K | ﹤0.01% | 972 |
|
|
2022
Q4 | $85.3K | Buy |
+14,457
| New | +$85.3K | ﹤0.01% | 1119 |
|